Chintharlapalli and colleagues demonstrated, for the first time, that CDODA-Me, a synthetic derivative of glycyrrhetinic acid, acts by downregulating miR-27a that is accompanied by an enhanced expression of ZBTB10 and Myt-1 which produces cell cycle arrest in colon cancer cells. This evidence concerns the gene MYT1 and colonic neoplasm.